Commentary on: evaluation of a newly developed 2D parametric parenchymal blood flow technique with an automated vessel suppression algorithm in patients with chronic thromboembolic pulmonary hypertension undergoing balloon pulmonary angioplasty

Chronic thromboembolic pulmonary hypertension (CTEPH) is a severe but potentially treatable cause of pulmonary hypertension, which is characterized by remodelling of the pulmonary arteries due to persistent occlusion of large and medium sized pulmonary arteries by highly adherent, organized thrombi. Inadequate clearance of thrombi can lead to small-vessel disease through unresolved thrombi, altered blood flow, and proliferative remodeling.1 Prognosis is poor without treatment, and pulmonary endarterectomy is well established as the definitive and potentially curative treatment method for CTEPH;2 however, in patients with distal disease, surgery is not an option.

Source: Clinical Radiology - March 21, 2019 Category: Radiology Authors: Y. Shahin, A.M. Rothman Tags: Commentary Source Type: research